is reporting from
Member
NP Rank:
NP Rank:
Washington - Rimonabant, a weight loss drug that was believed to increase the risk of suicidal thoughts, was unanimously rejected by a panel of federal health advisers, especially after Sanofi-Aventis SA, the manufacturer, was unable to show that the drug is safe.
Comments (0)